News

2016 08 30

PROFARMA is transferring technology for biosimilar ranibizumab to GMP facility and planning further clinical trials

Read more

 


2016 08 30

Career oportunities

Read more

 


Contacts
JSC "PROFARMA"


V.A. Graiciuno 8, LT-02241,
Vilnius, Lithuania


Tel. +370 5 2629761,
Fax: +370 5 2602116

E-mail: info@profarma.lt